nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Epirubicin—uterine cancer	0.309	0.433	CbGbCtD
Moxifloxacin—TOP2A—Etoposide—uterine cancer	0.241	0.337	CbGbCtD
Moxifloxacin—TOP2A—Doxorubicin—uterine cancer	0.164	0.23	CbGbCtD
Moxifloxacin—TOP2A—myometrium—uterine cancer	0.00339	0.168	CbGeAlD
Moxifloxacin—TOP2A—uterine cervix—uterine cancer	0.00264	0.131	CbGeAlD
Moxifloxacin—TOP2A—decidua—uterine cancer	0.00251	0.125	CbGeAlD
Moxifloxacin—TOP2A—endometrium—uterine cancer	0.00239	0.118	CbGeAlD
Moxifloxacin—TOP2A—mammalian vulva—uterine cancer	0.00231	0.114	CbGeAlD
Moxifloxacin—TOP2A—uterus—uterine cancer	0.0022	0.109	CbGeAlD
Moxifloxacin—TOP2A—female gonad—uterine cancer	0.0018	0.0891	CbGeAlD
Moxifloxacin—TOP2A—vagina—uterine cancer	0.00179	0.0886	CbGeAlD
Moxifloxacin—TOP2A—lymph node—uterine cancer	0.00116	0.0573	CbGeAlD
Moxifloxacin—TOP2A—Podofilox—Etoposide—uterine cancer	0.000773	0.136	CbGdCrCtD
Moxifloxacin—TOP2A—Teniposide—Etoposide—uterine cancer	0.000773	0.136	CbGdCrCtD
Moxifloxacin—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.00063	0.111	CbGdCrCtD
Moxifloxacin—TOP2A—Methyltestosterone—Progesterone—uterine cancer	0.00055	0.0965	CbGdCrCtD
Moxifloxacin—TOP2A—Doxorubicin—Epirubicin—uterine cancer	0.000403	0.0708	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Epirubicin—uterine cancer	0.000403	0.0708	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Epirubicin—uterine cancer	0.000403	0.0708	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	0.000373	0.0655	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—uterine cancer	0.000373	0.0655	CbGdCrCtD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—uterine cancer	0.000373	0.0655	CbGdCrCtD
Moxifloxacin—TOP2A—Norethindrone—Progesterone—uterine cancer	0.000358	0.0629	CbGdCrCtD
Moxifloxacin—TOP2A—Levonorgestrel—Progesterone—uterine cancer	0.000285	0.05	CbGdCrCtD
Moxifloxacin—Neutropenia—Epirubicin—uterine cancer	9.92e-05	0.000381	CcSEcCtD
Moxifloxacin—Abdominal distension—Doxorubicin—uterine cancer	9.88e-05	0.00038	CcSEcCtD
Moxifloxacin—Dysphagia—Doxorubicin—uterine cancer	9.82e-05	0.000377	CcSEcCtD
Moxifloxacin—Asthma—Doxorubicin—uterine cancer	9.82e-05	0.000377	CcSEcCtD
Moxifloxacin—Pollakiuria—Epirubicin—uterine cancer	9.8e-05	0.000377	CcSEcCtD
Moxifloxacin—Eosinophilia—Doxorubicin—uterine cancer	9.72e-05	0.000374	CcSEcCtD
Moxifloxacin—Photosensitivity reaction—Epirubicin—uterine cancer	9.69e-05	0.000372	CcSEcCtD
Moxifloxacin—Paraesthesia—Etoposide—uterine cancer	9.67e-05	0.000372	CcSEcCtD
Moxifloxacin—Weight increased—Epirubicin—uterine cancer	9.66e-05	0.000371	CcSEcCtD
Moxifloxacin—Pancreatitis—Doxorubicin—uterine cancer	9.63e-05	0.00037	CcSEcCtD
Moxifloxacin—Dyspnoea—Etoposide—uterine cancer	9.6e-05	0.000369	CcSEcCtD
Moxifloxacin—Hyperglycaemia—Epirubicin—uterine cancer	9.57e-05	0.000368	CcSEcCtD
Moxifloxacin—Somnolence—Etoposide—uterine cancer	9.57e-05	0.000368	CcSEcCtD
Moxifloxacin—Angina pectoris—Doxorubicin—uterine cancer	9.56e-05	0.000368	CcSEcCtD
Moxifloxacin—Pneumonia—Epirubicin—uterine cancer	9.52e-05	0.000366	CcSEcCtD
Moxifloxacin—Infestation NOS—Epirubicin—uterine cancer	9.46e-05	0.000364	CcSEcCtD
Moxifloxacin—Infestation—Epirubicin—uterine cancer	9.46e-05	0.000364	CcSEcCtD
Moxifloxacin—Vomiting—Dactinomycin—uterine cancer	9.46e-05	0.000364	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	9.38e-05	0.000361	CcSEcCtD
Moxifloxacin—Rash—Dactinomycin—uterine cancer	9.38e-05	0.000361	CcSEcCtD
Moxifloxacin—Decreased appetite—Etoposide—uterine cancer	9.36e-05	0.00036	CcSEcCtD
Moxifloxacin—Pancytopenia—Doxorubicin—uterine cancer	9.32e-05	0.000358	CcSEcCtD
Moxifloxacin—Renal failure—Epirubicin—uterine cancer	9.3e-05	0.000358	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Etoposide—uterine cancer	9.29e-05	0.000357	CcSEcCtD
Moxifloxacin—Fatigue—Etoposide—uterine cancer	9.28e-05	0.000357	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Epirubicin—uterine cancer	9.27e-05	0.000357	CcSEcCtD
Moxifloxacin—Stomatitis—Epirubicin—uterine cancer	9.22e-05	0.000355	CcSEcCtD
Moxifloxacin—Jaundice—Epirubicin—uterine cancer	9.22e-05	0.000355	CcSEcCtD
Moxifloxacin—Constipation—Etoposide—uterine cancer	9.21e-05	0.000354	CcSEcCtD
Moxifloxacin—Pain—Etoposide—uterine cancer	9.21e-05	0.000354	CcSEcCtD
Moxifloxacin—Urinary tract infection—Epirubicin—uterine cancer	9.2e-05	0.000354	CcSEcCtD
Moxifloxacin—Conjunctivitis—Epirubicin—uterine cancer	9.2e-05	0.000354	CcSEcCtD
Moxifloxacin—Dysuria—Doxorubicin—uterine cancer	9.18e-05	0.000353	CcSEcCtD
Moxifloxacin—Neutropenia—Doxorubicin—uterine cancer	9.18e-05	0.000353	CcSEcCtD
Moxifloxacin—Sweating—Epirubicin—uterine cancer	9.07e-05	0.000349	CcSEcCtD
Moxifloxacin—Pollakiuria—Doxorubicin—uterine cancer	9.07e-05	0.000349	CcSEcCtD
Moxifloxacin—Haematuria—Epirubicin—uterine cancer	9.02e-05	0.000347	CcSEcCtD
Moxifloxacin—Photosensitivity reaction—Doxorubicin—uterine cancer	8.96e-05	0.000345	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Epirubicin—uterine cancer	8.95e-05	0.000344	CcSEcCtD
Moxifloxacin—Weight increased—Doxorubicin—uterine cancer	8.94e-05	0.000344	CcSEcCtD
Moxifloxacin—Epistaxis—Epirubicin—uterine cancer	8.92e-05	0.000343	CcSEcCtD
Moxifloxacin—Sinusitis—Epirubicin—uterine cancer	8.88e-05	0.000341	CcSEcCtD
Moxifloxacin—Feeling abnormal—Etoposide—uterine cancer	8.87e-05	0.000341	CcSEcCtD
Moxifloxacin—Hyperglycaemia—Doxorubicin—uterine cancer	8.86e-05	0.000341	CcSEcCtD
Moxifloxacin—Nausea—Dactinomycin—uterine cancer	8.83e-05	0.00034	CcSEcCtD
Moxifloxacin—Agranulocytosis—Epirubicin—uterine cancer	8.83e-05	0.000339	CcSEcCtD
Moxifloxacin—Pneumonia—Doxorubicin—uterine cancer	8.81e-05	0.000339	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Etoposide—uterine cancer	8.8e-05	0.000338	CcSEcCtD
Moxifloxacin—Infestation NOS—Doxorubicin—uterine cancer	8.75e-05	0.000337	CcSEcCtD
Moxifloxacin—Infestation—Doxorubicin—uterine cancer	8.75e-05	0.000337	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	8.68e-05	0.000334	CcSEcCtD
Moxifloxacin—Bradycardia—Epirubicin—uterine cancer	8.65e-05	0.000332	CcSEcCtD
Moxifloxacin—Renal failure—Doxorubicin—uterine cancer	8.61e-05	0.000331	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Doxorubicin—uterine cancer	8.58e-05	0.00033	CcSEcCtD
Moxifloxacin—Urticaria—Etoposide—uterine cancer	8.55e-05	0.000329	CcSEcCtD
Moxifloxacin—Haemoglobin—Epirubicin—uterine cancer	8.54e-05	0.000328	CcSEcCtD
Moxifloxacin—Stomatitis—Doxorubicin—uterine cancer	8.53e-05	0.000328	CcSEcCtD
Moxifloxacin—Jaundice—Doxorubicin—uterine cancer	8.53e-05	0.000328	CcSEcCtD
Moxifloxacin—Rhinitis—Epirubicin—uterine cancer	8.52e-05	0.000327	CcSEcCtD
Moxifloxacin—Abdominal pain—Etoposide—uterine cancer	8.51e-05	0.000327	CcSEcCtD
Moxifloxacin—Body temperature increased—Etoposide—uterine cancer	8.51e-05	0.000327	CcSEcCtD
Moxifloxacin—Urinary tract infection—Doxorubicin—uterine cancer	8.51e-05	0.000327	CcSEcCtD
Moxifloxacin—Conjunctivitis—Doxorubicin—uterine cancer	8.51e-05	0.000327	CcSEcCtD
Moxifloxacin—Haemorrhage—Epirubicin—uterine cancer	8.49e-05	0.000327	CcSEcCtD
Moxifloxacin—Hepatitis—Epirubicin—uterine cancer	8.49e-05	0.000327	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Epirubicin—uterine cancer	8.45e-05	0.000325	CcSEcCtD
Moxifloxacin—Pharyngitis—Epirubicin—uterine cancer	8.43e-05	0.000324	CcSEcCtD
Moxifloxacin—Sweating—Doxorubicin—uterine cancer	8.39e-05	0.000323	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Epirubicin—uterine cancer	8.39e-05	0.000322	CcSEcCtD
Moxifloxacin—Oedema peripheral—Epirubicin—uterine cancer	8.37e-05	0.000322	CcSEcCtD
Moxifloxacin—Haematuria—Doxorubicin—uterine cancer	8.35e-05	0.000321	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Epirubicin—uterine cancer	8.35e-05	0.000321	CcSEcCtD
Moxifloxacin—Urethral disorder—Epirubicin—uterine cancer	8.33e-05	0.00032	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Doxorubicin—uterine cancer	8.28e-05	0.000318	CcSEcCtD
Moxifloxacin—Epistaxis—Doxorubicin—uterine cancer	8.26e-05	0.000317	CcSEcCtD
Moxifloxacin—Sinusitis—Doxorubicin—uterine cancer	8.21e-05	0.000316	CcSEcCtD
Moxifloxacin—Visual impairment—Epirubicin—uterine cancer	8.19e-05	0.000315	CcSEcCtD
Moxifloxacin—Agranulocytosis—Doxorubicin—uterine cancer	8.17e-05	0.000314	CcSEcCtD
Moxifloxacin—Erythema multiforme—Epirubicin—uterine cancer	8.03e-05	0.000309	CcSEcCtD
Moxifloxacin—Bradycardia—Doxorubicin—uterine cancer	8e-05	0.000308	CcSEcCtD
Moxifloxacin—Eye disorder—Epirubicin—uterine cancer	7.94e-05	0.000305	CcSEcCtD
Moxifloxacin—Hypersensitivity—Etoposide—uterine cancer	7.93e-05	0.000305	CcSEcCtD
Moxifloxacin—Tinnitus—Epirubicin—uterine cancer	7.92e-05	0.000304	CcSEcCtD
Moxifloxacin—Haemoglobin—Doxorubicin—uterine cancer	7.9e-05	0.000304	CcSEcCtD
Moxifloxacin—Cardiac disorder—Epirubicin—uterine cancer	7.88e-05	0.000303	CcSEcCtD
Moxifloxacin—Rhinitis—Doxorubicin—uterine cancer	7.88e-05	0.000303	CcSEcCtD
Moxifloxacin—Hepatitis—Doxorubicin—uterine cancer	7.86e-05	0.000302	CcSEcCtD
Moxifloxacin—Haemorrhage—Doxorubicin—uterine cancer	7.86e-05	0.000302	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Doxorubicin—uterine cancer	7.82e-05	0.000301	CcSEcCtD
Moxifloxacin—Pharyngitis—Doxorubicin—uterine cancer	7.8e-05	0.0003	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Doxorubicin—uterine cancer	7.76e-05	0.000298	CcSEcCtD
Moxifloxacin—Oedema peripheral—Doxorubicin—uterine cancer	7.74e-05	0.000298	CcSEcCtD
Moxifloxacin—Asthenia—Etoposide—uterine cancer	7.72e-05	0.000297	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Doxorubicin—uterine cancer	7.72e-05	0.000297	CcSEcCtD
Moxifloxacin—Angiopathy—Epirubicin—uterine cancer	7.71e-05	0.000296	CcSEcCtD
Moxifloxacin—Urethral disorder—Doxorubicin—uterine cancer	7.7e-05	0.000296	CcSEcCtD
Moxifloxacin—Immune system disorder—Epirubicin—uterine cancer	7.67e-05	0.000295	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Epirubicin—uterine cancer	7.65e-05	0.000294	CcSEcCtD
Moxifloxacin—Chills—Epirubicin—uterine cancer	7.62e-05	0.000293	CcSEcCtD
Moxifloxacin—Pruritus—Etoposide—uterine cancer	7.62e-05	0.000293	CcSEcCtD
Moxifloxacin—Arrhythmia—Epirubicin—uterine cancer	7.59e-05	0.000292	CcSEcCtD
Moxifloxacin—Visual impairment—Doxorubicin—uterine cancer	7.57e-05	0.000291	CcSEcCtD
Moxifloxacin—Mental disorder—Epirubicin—uterine cancer	7.44e-05	0.000286	CcSEcCtD
Moxifloxacin—Erythema multiforme—Doxorubicin—uterine cancer	7.43e-05	0.000286	CcSEcCtD
Moxifloxacin—Erythema—Epirubicin—uterine cancer	7.39e-05	0.000284	CcSEcCtD
Moxifloxacin—Malnutrition—Epirubicin—uterine cancer	7.39e-05	0.000284	CcSEcCtD
Moxifloxacin—Diarrhoea—Etoposide—uterine cancer	7.37e-05	0.000283	CcSEcCtD
Moxifloxacin—Eye disorder—Doxorubicin—uterine cancer	7.34e-05	0.000282	CcSEcCtD
Moxifloxacin—Tinnitus—Doxorubicin—uterine cancer	7.33e-05	0.000282	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—uterine cancer	7.29e-05	0.00028	CcSEcCtD
Moxifloxacin—Flatulence—Epirubicin—uterine cancer	7.29e-05	0.00028	CcSEcCtD
Moxifloxacin—Tension—Epirubicin—uterine cancer	7.26e-05	0.000279	CcSEcCtD
Moxifloxacin—Dysgeusia—Epirubicin—uterine cancer	7.24e-05	0.000278	CcSEcCtD
Moxifloxacin—Nervousness—Epirubicin—uterine cancer	7.18e-05	0.000276	CcSEcCtD
Moxifloxacin—Back pain—Epirubicin—uterine cancer	7.15e-05	0.000275	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—uterine cancer	7.13e-05	0.000274	CcSEcCtD
Moxifloxacin—Dizziness—Etoposide—uterine cancer	7.12e-05	0.000274	CcSEcCtD
Moxifloxacin—Muscle spasms—Epirubicin—uterine cancer	7.11e-05	0.000273	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—uterine cancer	7.1e-05	0.000273	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—uterine cancer	7.08e-05	0.000272	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—uterine cancer	7.05e-05	0.000271	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—uterine cancer	7.02e-05	0.00027	CcSEcCtD
Moxifloxacin—Vision blurred—Epirubicin—uterine cancer	6.97e-05	0.000268	CcSEcCtD
Moxifloxacin—Mental disorder—Doxorubicin—uterine cancer	6.89e-05	0.000265	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Epirubicin—uterine cancer	6.86e-05	0.000264	CcSEcCtD
Moxifloxacin—Vomiting—Etoposide—uterine cancer	6.84e-05	0.000263	CcSEcCtD
Moxifloxacin—Erythema—Doxorubicin—uterine cancer	6.84e-05	0.000263	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—uterine cancer	6.84e-05	0.000263	CcSEcCtD
Moxifloxacin—Anaemia—Epirubicin—uterine cancer	6.83e-05	0.000263	CcSEcCtD
Moxifloxacin—Agitation—Epirubicin—uterine cancer	6.79e-05	0.000261	CcSEcCtD
Moxifloxacin—Rash—Etoposide—uterine cancer	6.79e-05	0.000261	CcSEcCtD
Moxifloxacin—Dermatitis—Etoposide—uterine cancer	6.78e-05	0.000261	CcSEcCtD
Moxifloxacin—Headache—Etoposide—uterine cancer	6.74e-05	0.000259	CcSEcCtD
Moxifloxacin—Flatulence—Doxorubicin—uterine cancer	6.74e-05	0.000259	CcSEcCtD
Moxifloxacin—Tension—Doxorubicin—uterine cancer	6.71e-05	0.000258	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—uterine cancer	6.7e-05	0.000258	CcSEcCtD
Moxifloxacin—Malaise—Epirubicin—uterine cancer	6.67e-05	0.000256	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—uterine cancer	6.64e-05	0.000255	CcSEcCtD
Moxifloxacin—Vertigo—Epirubicin—uterine cancer	6.64e-05	0.000255	CcSEcCtD
Moxifloxacin—Syncope—Epirubicin—uterine cancer	6.63e-05	0.000255	CcSEcCtD
Moxifloxacin—Leukopenia—Epirubicin—uterine cancer	6.62e-05	0.000254	CcSEcCtD
Moxifloxacin—Back pain—Doxorubicin—uterine cancer	6.62e-05	0.000254	CcSEcCtD
Moxifloxacin—Muscle spasms—Doxorubicin—uterine cancer	6.58e-05	0.000253	CcSEcCtD
Moxifloxacin—Palpitations—Epirubicin—uterine cancer	6.53e-05	0.000251	CcSEcCtD
Moxifloxacin—Loss of consciousness—Epirubicin—uterine cancer	6.5e-05	0.00025	CcSEcCtD
Moxifloxacin—Cough—Epirubicin—uterine cancer	6.45e-05	0.000248	CcSEcCtD
Moxifloxacin—Vision blurred—Doxorubicin—uterine cancer	6.45e-05	0.000248	CcSEcCtD
Moxifloxacin—Convulsion—Epirubicin—uterine cancer	6.41e-05	0.000246	CcSEcCtD
Moxifloxacin—Nausea—Etoposide—uterine cancer	6.39e-05	0.000246	CcSEcCtD
Moxifloxacin—Hypertension—Epirubicin—uterine cancer	6.38e-05	0.000245	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—uterine cancer	6.35e-05	0.000244	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—uterine cancer	6.32e-05	0.000243	CcSEcCtD
Moxifloxacin—Myalgia—Epirubicin—uterine cancer	6.29e-05	0.000242	CcSEcCtD
Moxifloxacin—Chest pain—Epirubicin—uterine cancer	6.29e-05	0.000242	CcSEcCtD
Moxifloxacin—Arthralgia—Epirubicin—uterine cancer	6.29e-05	0.000242	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—uterine cancer	6.29e-05	0.000242	CcSEcCtD
Moxifloxacin—Anxiety—Epirubicin—uterine cancer	6.27e-05	0.000241	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	6.25e-05	0.00024	CcSEcCtD
Moxifloxacin—Discomfort—Epirubicin—uterine cancer	6.22e-05	0.000239	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—uterine cancer	6.17e-05	0.000237	CcSEcCtD
Moxifloxacin—Dry mouth—Epirubicin—uterine cancer	6.16e-05	0.000237	CcSEcCtD
Moxifloxacin—Vertigo—Doxorubicin—uterine cancer	6.15e-05	0.000236	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—uterine cancer	6.14e-05	0.000236	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—uterine cancer	6.12e-05	0.000235	CcSEcCtD
Moxifloxacin—Confusional state—Epirubicin—uterine cancer	6.08e-05	0.000234	CcSEcCtD
Moxifloxacin—Palpitations—Doxorubicin—uterine cancer	6.05e-05	0.000232	CcSEcCtD
Moxifloxacin—Oedema—Epirubicin—uterine cancer	6.03e-05	0.000232	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Epirubicin—uterine cancer	6.03e-05	0.000232	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—uterine cancer	6.01e-05	0.000231	CcSEcCtD
Moxifloxacin—Cough—Doxorubicin—uterine cancer	5.97e-05	0.00023	CcSEcCtD
Moxifloxacin—Shock—Epirubicin—uterine cancer	5.94e-05	0.000228	CcSEcCtD
Moxifloxacin—Convulsion—Doxorubicin—uterine cancer	5.93e-05	0.000228	CcSEcCtD
Moxifloxacin—Nervous system disorder—Epirubicin—uterine cancer	5.92e-05	0.000228	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Epirubicin—uterine cancer	5.91e-05	0.000227	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—uterine cancer	5.91e-05	0.000227	CcSEcCtD
Moxifloxacin—Tachycardia—Epirubicin—uterine cancer	5.89e-05	0.000226	CcSEcCtD
Moxifloxacin—Skin disorder—Epirubicin—uterine cancer	5.86e-05	0.000225	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Epirubicin—uterine cancer	5.83e-05	0.000224	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—uterine cancer	5.82e-05	0.000224	CcSEcCtD
Moxifloxacin—Myalgia—Doxorubicin—uterine cancer	5.82e-05	0.000224	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—uterine cancer	5.82e-05	0.000224	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—uterine cancer	5.8e-05	0.000223	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	5.78e-05	0.000222	CcSEcCtD
Moxifloxacin—Discomfort—Doxorubicin—uterine cancer	5.75e-05	0.000221	CcSEcCtD
Moxifloxacin—Anorexia—Epirubicin—uterine cancer	5.75e-05	0.000221	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—uterine cancer	5.7e-05	0.000219	CcSEcCtD
Moxifloxacin—Hypotension—Epirubicin—uterine cancer	5.64e-05	0.000217	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—uterine cancer	5.63e-05	0.000216	CcSEcCtD
Moxifloxacin—Oedema—Doxorubicin—uterine cancer	5.58e-05	0.000215	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—uterine cancer	5.58e-05	0.000215	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Epirubicin—uterine cancer	5.5e-05	0.000211	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—uterine cancer	5.49e-05	0.000211	CcSEcCtD
Moxifloxacin—Nervous system disorder—Doxorubicin—uterine cancer	5.48e-05	0.000211	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—uterine cancer	5.47e-05	0.00021	CcSEcCtD
Moxifloxacin—Insomnia—Epirubicin—uterine cancer	5.46e-05	0.00021	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—uterine cancer	5.45e-05	0.00021	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—uterine cancer	5.42e-05	0.000209	CcSEcCtD
Moxifloxacin—Paraesthesia—Epirubicin—uterine cancer	5.42e-05	0.000208	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—uterine cancer	5.4e-05	0.000208	CcSEcCtD
Moxifloxacin—Dyspnoea—Epirubicin—uterine cancer	5.38e-05	0.000207	CcSEcCtD
Moxifloxacin—Somnolence—Epirubicin—uterine cancer	5.36e-05	0.000206	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—uterine cancer	5.32e-05	0.000205	CcSEcCtD
Moxifloxacin—Dyspepsia—Epirubicin—uterine cancer	5.31e-05	0.000204	CcSEcCtD
Moxifloxacin—Decreased appetite—Epirubicin—uterine cancer	5.25e-05	0.000202	CcSEcCtD
Moxifloxacin—Hypotension—Doxorubicin—uterine cancer	5.22e-05	0.000201	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Epirubicin—uterine cancer	5.21e-05	0.0002	CcSEcCtD
Moxifloxacin—Fatigue—Epirubicin—uterine cancer	5.2e-05	0.0002	CcSEcCtD
Moxifloxacin—Pain—Epirubicin—uterine cancer	5.16e-05	0.000198	CcSEcCtD
Moxifloxacin—Constipation—Epirubicin—uterine cancer	5.16e-05	0.000198	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.09e-05	0.000196	CcSEcCtD
Moxifloxacin—Insomnia—Doxorubicin—uterine cancer	5.05e-05	0.000194	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—uterine cancer	5.01e-05	0.000193	CcSEcCtD
Moxifloxacin—Dyspnoea—Doxorubicin—uterine cancer	4.98e-05	0.000191	CcSEcCtD
Moxifloxacin—Feeling abnormal—Epirubicin—uterine cancer	4.97e-05	0.000191	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—uterine cancer	4.96e-05	0.000191	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Epirubicin—uterine cancer	4.93e-05	0.00019	CcSEcCtD
Moxifloxacin—Dyspepsia—Doxorubicin—uterine cancer	4.91e-05	0.000189	CcSEcCtD
Moxifloxacin—Decreased appetite—Doxorubicin—uterine cancer	4.85e-05	0.000187	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.82e-05	0.000185	CcSEcCtD
Moxifloxacin—Fatigue—Doxorubicin—uterine cancer	4.81e-05	0.000185	CcSEcCtD
Moxifloxacin—Urticaria—Epirubicin—uterine cancer	4.79e-05	0.000184	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—uterine cancer	4.77e-05	0.000184	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—uterine cancer	4.77e-05	0.000184	CcSEcCtD
Moxifloxacin—Abdominal pain—Epirubicin—uterine cancer	4.77e-05	0.000183	CcSEcCtD
Moxifloxacin—Body temperature increased—Epirubicin—uterine cancer	4.77e-05	0.000183	CcSEcCtD
Moxifloxacin—Feeling abnormal—Doxorubicin—uterine cancer	4.6e-05	0.000177	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—uterine cancer	4.57e-05	0.000176	CcSEcCtD
Moxifloxacin—Hypersensitivity—Epirubicin—uterine cancer	4.45e-05	0.000171	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—uterine cancer	4.44e-05	0.000171	CcSEcCtD
Moxifloxacin—Abdominal pain—Doxorubicin—uterine cancer	4.41e-05	0.00017	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—uterine cancer	4.41e-05	0.00017	CcSEcCtD
Moxifloxacin—Asthenia—Epirubicin—uterine cancer	4.33e-05	0.000166	CcSEcCtD
Moxifloxacin—Pruritus—Epirubicin—uterine cancer	4.27e-05	0.000164	CcSEcCtD
Moxifloxacin—Diarrhoea—Epirubicin—uterine cancer	4.13e-05	0.000159	CcSEcCtD
Moxifloxacin—Hypersensitivity—Doxorubicin—uterine cancer	4.11e-05	0.000158	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—uterine cancer	4.01e-05	0.000154	CcSEcCtD
Moxifloxacin—Dizziness—Epirubicin—uterine cancer	3.99e-05	0.000153	CcSEcCtD
Moxifloxacin—Pruritus—Doxorubicin—uterine cancer	3.95e-05	0.000152	CcSEcCtD
Moxifloxacin—Vomiting—Epirubicin—uterine cancer	3.84e-05	0.000148	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—uterine cancer	3.82e-05	0.000147	CcSEcCtD
Moxifloxacin—Rash—Epirubicin—uterine cancer	3.8e-05	0.000146	CcSEcCtD
Moxifloxacin—Dermatitis—Epirubicin—uterine cancer	3.8e-05	0.000146	CcSEcCtD
Moxifloxacin—Headache—Epirubicin—uterine cancer	3.78e-05	0.000145	CcSEcCtD
Moxifloxacin—Dizziness—Doxorubicin—uterine cancer	3.69e-05	0.000142	CcSEcCtD
Moxifloxacin—Nausea—Epirubicin—uterine cancer	3.58e-05	0.000138	CcSEcCtD
Moxifloxacin—Vomiting—Doxorubicin—uterine cancer	3.55e-05	0.000136	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—uterine cancer	3.52e-05	0.000135	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—uterine cancer	3.52e-05	0.000135	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—uterine cancer	3.5e-05	0.000134	CcSEcCtD
Moxifloxacin—Nausea—Doxorubicin—uterine cancer	3.32e-05	0.000128	CcSEcCtD
